Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Aug;13(4):321-327.
doi: 10.1007/s12519-017-0014-9. Epub 2017 Jan 27.

Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children

Li-Shen Shan  1 , Xin Liu  2 , Xin-Yuan Kang  3 , Fei Wang  2 , Xiao-Hua Han  2 , Yun-Xiao Shang  2
Affiliations
Comparative Study

Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children

Li-Shen Shan et al. World J Pediatr. 2017 Aug.

Abstract

Background: The prevalence of Mycoplasma pneumoniae pneumonia has increased considerably in recent years. To evaluate the efficacy of combined treatment of azithromycin with intravenous immunoglo-bulin (IVIG) or methylprednisolone in children with refractory Mycoplasma pneumoniae pneumonia (RMPP).

Methods: Children with RMPP were randomly allocated to group A [intravenous azithromycin (IA)+ methylprednisolone], group B (IA+IVIG) or group C (IA alone). Following a 7-day treatment, group C patients were randomly separated into two sub-groups: group C1 (IA+methylprednisolone) and group C2 (IA+IVIG). Temperature, respiratory symptoms and signs were examined. The average febrile period after treatment (F2), average total febrile period (F3), infiltration absorption, atelectasis resolution, pleural effusion disappearance were determined. The levels of C-reactive protein (CRP), D-dimer, and lactate dehydrogenase (LDH) were measured.

Results: Seven days after enrollment, the average F2 after treatment of group A was the shortest. Compared with the control group C, the combined treatment group A and B showed higher rates of infiltration absorption, atelectasis resolution and pleural effusion disappearance, while lower levels of serum CRP, D-dimer and LDH. Fourteen days after enrollment, all children with combined therapy clinically improved, and presented better laboratory results. Group C1 showed shorter F3 and lower levels of CRP and LDH than those of group C2. Overall, group A showed the shortest F3, also has the lowest CRP and LDH.

Conclusions: Azithromycin with IVIG or methylprednisolone was better treatment for children with RMPP than azithromycin alone. IVIG treatment may be beneficial, especially when the efficacy of corticosteroids is insecure, thus could be considered as an alternative of primary therapeutic approaches.

Keywords: immunoglobulin; methylprednisolone; refractory Mycoplasma pneumoniae pneumonia.

PubMed Disclaimer

References

    1. Zhongguo Dang Dai Er Ke Za Zhi. 2013 Aug;15(8):619-22 - PubMed
    1. J Neurol Sci. 1998 Apr 15;157(1):113-5 - PubMed
    1. J Microbiol Immunol Infect. 2002 Sep;35(3):173-8 - PubMed
    1. BMC Pediatr. 2010 Jul 06;10:48 - PubMed
    1. Transfus Med. 2002 Apr;12(2):133-9 - PubMed

MeSH terms

LinkOut - more resources